Abstract
Purpose:
Nerve fiber density in the cornea is an alternative marker for diabetic peripheral neuropathy combined with intraepidermal nerve fiber density (IENFD). Recent studies investigated corneal nerves using rodent models of diabetes. Male Wistar Bon Kobori (WBN/Kob) rats spontaneously develop long-lasting diabetes and human-like diabetic peripheral neuropathy with vascular lesions. This study investigated corneal nerve fiber density and IENFD in diabetic male WBN/Kob rats as morphological markers of diabetic peripheral neuropathy.
Methods:
Male WBN/Kob rats exhibit abnormal glucose tolerance and diabetes at approximately 30 weeks of age, which progresses until approximately 90 weeks of age. Male WBN/Kob rats aged 36 and 90 weeks were therefore used for histological investigations and compared with age-matched nondiabetic female rats.
Results:
Terminal epithelial nerve density and subbasal nerve plexus density in the central cornea were significantly greater in nondiabetic female rats aged 90 weeks when compared with nondiabetic female rats aged 36 weeks. However, terminal epithelial nerve density and subbasal nerve plexus density did not increase with age in diabetic male WBN/Kob rats, instead lowering by up to 40%, relative to measurements in nondiabetic female rats aged 90 weeks. However, this difference was not statistically significant. IENFD was significantly lower in diabetic male rats aged 90 weeks than in male rats aged 36 weeks, but did not differ between diabetic male rats and nondiabetic female rats aged 90 weeks.
Conclusions:
In WBN/Kob rats, hyperglycemia suppresses an age-related increase in peripheral sensory corneal nerve density; therefore, corneal sensory nerves may be important morphological markers of diabetic peripheral sensory neuropathy.
Peripheral neuropathy constitutes a major complication of diabetes mellitus. A widely used method for the morphological analysis of diabetic peripheral neuropathy comprises sural nerve biopsy.
1–4 However, because of the high invasiveness of this method, skin biopsy for assessment of intradermal nerve fiber density (IENFD) is the recommended standard method.
5,6 Moreover, corneal confocal microscopy has become popular for the evaluation of small corneal nerve fibers and represents an alternative method for assessment of peripheral neuropathy.
6–11
Animal models of diabetes are used to analyze diabetic peripheral neuropathy. Using animal models, corneal nerves have been examined, along with intradermal and sural nerves, to evaluate morphological characteristics of diabetic complications. In these studies, most experiments used rats and mice with streptozotocin (STZ)-induced diabetes.
12–19 Notably, the results have been contradictory, such that a subset of studies demonstrated considerable reduction in fiber density,
12–19 whereas others have reported no abnormalities.
20,21 Recently, we reported that, following long-term (35 weeks) hyperglycemia, mice with STZ-induced and alloxan-induced type 1 diabetes exhibited significant reductions in corneal sensory nerve fiber density.
22 Our findings suggested that extended exposure to hyperglycemia could cause corneal lesions in mice with STZ-induced or alloxan-induced type 1 diabetes.
STZ-induced diabetic rats and mice show rapid and overt hyperglycemia, slow nerve conduction, and a mild degree of axonal atrophy. However, peripheral nerves in STZ-induced diabetic mice generally do not show clear demyelination, degeneration, or fiber loss, whereas these findings are commonly observed in diabetic patients. Male WBN/Kob rats develop long-lasting hyperglycemia, glucosuria, hypoinsulinemia, and severe diabetic peripheral motor neuropathy, including axonal atrophy, segmental demyelination, and reduced motor nerve conduction velocity.
23–29 Motor nerve conduction velocity and peripheral motor neuropathy are detectable at approximately 12 months old and deteriorate with the duration of hyperglycemia.
23,24,26 In addition, an endoneurial microangiopathic change usually found in human diabetic neuropathic patients is also seen.
24,26 However, the animals develop chronic pancreatitis, which is not the underlying basis of type 1 or type 2 diabetes,
30 and also manifest motor rather than sensory abnormalities.
23,24 Despite this, insulin treatment can decrease peripheral motor neuropathy without motor nerve conduction velocity in diabetic Wistar Bon Kobori (WBN/Kob) rats, and the neuronal changes observed in them may be induced by hyperglycemia and hypoinsulinemia.
29 Thus, male WBN/Kob rats may be useful in the evaluation of hyperglycemia-related morphological changes in peripheral nerve changes. However, no previous analysis has been done on corneal and intradermal nerves of WBN/Kob rats, and morphological changes to the sensory nerve terminal have not yet been elucidated.
This study evaluated corneal nerve fiber density and IENFD in male diabetic WBN/Kob rats, relative to those of nondiabetic age-matched female WBN/Kob rats under short and long-lasting diabetic conditions to establish the usefulness of this model to study diabetic sensory neuropathy.